文献速递乳房整形与再造

评估乳房再造的价值:成本效果研究的系统综述

Assessing value in breast reconstruction: A systematic review of cost-effectiveness studies.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2017-10-09

该系统综述检索了截至2017年8月17日的PubMed、Web of Science和成本效果分析注册库,最终纳入13项报告增量成本效果比的研究。5项评估技术(脱细胞真皮基质、术前CT血管造影、吲哚菁绿血管造影、腹部补片加强),8项评估再造方法;具成本效果的策略包括游离对比带蒂腹部组织移植、直接植入对比分期假体再造、保留筋膜的游离腹部组织移植变体。

要点

  • 13项成本效果研究均报告增量成本效果比,涉及技术与再造方法两类。
  • 具成本效果的策略包括游离对比带蒂腹部组织移植、直接植入对比分期假体再造。
  • 保留筋膜的游离腹部组织移植变体也具成本效果。

核心结论

  • 当前证据显示多种技术和方式在完成成功乳房再造方面具成本效果。
  • 整形外科医生在与支付方和政策制定者讨论高价值乳房再造时应熟悉这些经济模型。

研究设计与样本

  • 系统综述,检索PubMed、Web of Science和成本效果分析注册库,由两名评价者独立评估截至2017年8月17日的所有发表文献。
  • 去除重复后筛选1996条记录,53项研究进行全文审查,最终纳入13项研究进行分析。

主要发现

  • 最终纳入分析的13项研究均提及增量成本效果比。
  • 5项研究评估技术成本效果:分期假体再造中的脱细胞真皮基质、直接植入再造中的脱细胞真皮基质、自体再造中的术前计算机断层血管造影、评估吻合口通畅性的吲哚菁绿染料血管造影、腹部组织移植中的腹部补片加强。
  • 其余8项研究评估不同再造方法的成本效果。
  • 具成本效果的策略包括游离对比带蒂腹部组织移植、直接植入对比分期假体再造、保留筋膜的游离腹部组织移植变体。

临床怎么用

  • 整形外科医生在与支付方和政策制定者讨论高价值乳房再造时应熟悉这些经济模型。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Breast reconstruction is one of the most common procedures performed by plastic surgeons and is achieved through various choices in both technology and method. Cost-effectiveness analyses are increasingly important in assessing differences in value between treatment options, which is relevant in a world of confined resources. A thorough evaluation of the cost-effectiveness literature can assist surgeons and health systems evaluate high-value care models. METHODS: A systematic review of PubMed, Web of Science, and the Cost-Effectiveness Analysis Registry was conducted. Two reviewers independently evaluated all publications up until August 17, 2017. RESULTS: After removal of duplicates, 1996 records were screened, from which 53 studies underwent full text review. All the 13 studies included for final analysis mention an incremental cost-effectiveness ratio. Five studies evaluated the cost-effectiveness of technologies including acellular dermal matrix (ADM) in staged prosthetic reconstruction, ADM in direct-to-implant (DTI) reconstruction, preoperative computed tomography angiography in autologous reconstruction, indocyanine green dye angiography in evaluating anastomotic patency, and abdominal mesh reinforcement in abdominal tissue transfer. The remaining eight studies evaluated the cost-effectiveness of different reconstruction methods. Cost-effective strategies included free vs. pedicled abdominal tissue transfer, DTI vs. staged prosthetic reconstruction, and fascia-sparing variants of free abdominal tissue transfer. CONCLUSIONS: Current evidence demonstrates multiple cost-effective technologies and methods in accomplishing successful breast reconstruction. Plastic surgeons should be well informed of such economic models when engaging payers and policymakers in discussions regarding high-value breast reconstruction.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Sheckter CC, Matros E, Momeni A, et al. Assessing value in breast reconstruction: A systematic review of cost-effectiveness studies. J Plast Reconstr Aesthet Surg. 2017. PMID: 29196176. doi:10.1016/j.bjps.2017.09.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。